gliclazide has been researched along with Bronchopulmonary Dysplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jianhua, F; Qing, C; Xindong, X; Xinyi, Z; Xuefei, Y; Ziyun, L | 1 |
1 other study(ies) available for gliclazide and Bronchopulmonary Dysplasia
| Article | Year |
|---|---|
Protective Effects of 18β-Glycyrrhetinic Acid on Neonatal Rats with Hyperoxia Exposure.
Topics: Animals; Animals, Newborn; Body Weight; Bronchopulmonary Dysplasia; Glycyrrhetinic Acid; Humans; Hyperoxia; Infant, Newborn; Infant, Premature; Inflammasomes; Lung; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxygen; Pneumonia; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2022 |